Related Experiment Video
Updated: Oct 7, 2025

09:01
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.3K
Engineering Near-Infrared-Excitable Metal-Organic Framework for Tumor Microenvironment Responsive Therapy
Jialin Lu1, Xiaohui Zhu1, Mingxia Li2
1School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China.
ACS Applied Bio Materials
|January 10, 2022
Summary
This study introduces a novel nanoplatform combining upconversion nanoparticles and metal-organic frameworks for advanced biomedical applications. This system uses near-infrared light for effective photodynamic therapy and chemotherapy against tumors.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Luminescent metal-organic frameworks (MOFs) offer exceptional optical properties but are limited in bioapplications by UV/visible light excitation.
- Traditional luminescent MOFs struggle with limited tissue penetration depth, hindering in vivo applications.
Purpose of the Study:
- To develop a novel nanoplatform (UCNP@MOF) for enhanced biomedical applications using near-infrared (NIR) light.
- To combine the unique properties of upconversion nanoparticles (UCNPs) and aluminum-based MOFs (Al-MOFs) for combined photodynamic therapy (PDT) and chemotherapy (CMT).
Main Methods:
- Synthesized core-shell UCNP@MOF nanocomposites using poly(vinylpyrrolidone) (PVP) for controlled Al-MOF layer nucleation on UCNP surfaces.
- Utilized a 980 nm laser to excite UCNPs, generating green light to activate Al-MOFs for singlet oxygen production.
- Incorporated doxorubicin hydrochloride (DOX) into the Al-MOF structure for pH-responsive drug delivery.
Main Results:
- The UCNP@MOF system successfully generated singlet oxygen upon NIR excitation for photodynamic therapy.
- Achieved pH-responsive release of doxorubicin hydrochloride from the MOF matrix.
- Demonstrated significant antitumor efficacy through the combined NIR-light-induced PDT and chemotherapy (CMT).
Conclusions:
- The developed UCNP@MOF nanoplatform offers a promising solution for overcoming the limitations of traditional luminescent MOFs in biomedical applications.
- The combination of UCNPs and MOFs provides a versatile platform for NIR-triggered combination therapy with excellent antitumor effects.
- This work highlights the potential of integrating UCNPs and MOFs for advanced diagnostics and therapeutics in medicine.

